Lebwohl, M.G., Mehta, N.N., Gottlieb, A.B. and Mendelsohn, A.M. 2020. Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s42. DOI:https://doi.org/10.25251/skin.4.supp.42.